"The high-throughput, highly sensitive cobas SARS-CoV-2 Test under
FDA Emergency Use Authorisation can now be used to test individual
or pooled samples from people without symptoms or other reasons to
suspect COVID-19," Roche said in a statement.
(Reporting by Brenna Hughes Neghaiwi; Editing by Riham Alkousaa)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |